Genomic biomarkers are DNA or RNA variations that can be analyzed to determine the risk, diagnosis, and progression of certain diseases. Biomarkers help in assessing drug responses, toxicity, and effectiveness of treatment by analyzing genetic alterations in cells. The growing burden of chronic diseases such as cancer has increased the funding for genomic research which is driving the growth of the genomic biomarker market. The global genomic biomarker market is estimated to be valued at ... Read more
